Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 97

1.

Five-slice technique for the explantation of complicated BrightOcular© cosmetic iris implants.

Shalash A, El Bahrawy M.

Int Ophthalmol. 2020 Mar 13. doi: 10.1007/s10792-020-01328-1. [Epub ahead of print]

PMID:
32166580
2.

Toxic Shock Syndrome Toxin 1 Evaluation and Antibiotic Impact in a Transgenic Model of Staphylococcal Soft Tissue Infection.

Sharma H, Turner CE, Siggins MK, El-Bahrawy M, Pichon B, Kearns A, Sriskandan S.

mSphere. 2019 Oct 9;4(5). pii: e00665-19. doi: 10.1128/mSphere.00665-19.

3.

A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases.

Meagher NS, Wang L, Rambau PF, Intermaggio MP, Huntsman DG, Wilkens LR, El-Bahrawy MA, Ness RB, Odunsi K, Steed H, Herpel E, Anglesio MS, Zhang B, Lambie N, Swerdlow AJ, Lubiński J, Vierkant RA, Goode EL, Menon U, Toloczko-Grabarek A, Oszurek O, Bilic S, Talhouk A, García-Closas M, Wang Q, Tan A, Farrell R, Kennedy CJ, Jimenez-Linan M, Sundfeldt K, Etter JL, Menkiszak J, Goodman MT, Klonowski P, Leung Y, Winham SJ, Moysich KB, Behrens S, Kluz T, Edwards RP, Gronwald J, Modugno F, Hernandez BY, Chow C, Kelemen LE, Keeney GL, Carney ME, Natanzon Y, Robertson G, Sharma R, Gayther SA, Alsop J, Luk H, Karpinskyj C, Campbell I, Sinn P, Gentry-Maharaj A, Coulson P, Chang-Claude J, Shah M, Widschwendter M, Tang K, Schoemaker MJ, Koziak JM, Cook LS, Brenton JD, Daley F, Kristjansdottir B, Mateoiu C, Larson MC, Harnett PR, Jung A, deFazio A, Gorringe KL, Pharoah PDP, Minoo P, Stewart C, Bathe OF, Gui X, Cohen P, Ramus SJ, Köbel M.

Mod Pathol. 2019 Dec;32(12):1834-1846. doi: 10.1038/s41379-019-0302-0. Epub 2019 Jun 25.

PMID:
31239549
4.

SHOC2 phosphatase-dependent RAF dimerization mediates resistance to MEK inhibition in RAS-mutant cancers.

Jones GG, Del Río IB, Sari S, Sekerim A, Young LC, Hartig N, Areso Zubiaur I, El-Bahrawy MA, Hynds RE, Lei W, Molina-Arcas M, Downward J, Rodriguez-Viciana P.

Nat Commun. 2019 Jun 10;10(1):2532. doi: 10.1038/s41467-019-10367-x.

5.

Superficial myofibroblastoma of the genital tract: a case report of the imaging findings.

Atinga A, El-Bahrawy M, Stewart V, Bharwani N.

BJR Case Rep. 2018 Aug 11;5(1):20180057. doi: 10.1259/bjrcr.20180057. eCollection 2019 Feb.

6.

Targeted next generation sequencing of pancreatic solid pseudopapillary neoplasms show mutations in Wnt signaling pathway genes.

Wang J, Gerrard G, Poskitt B, Dawson K, Trivedi P, Foroni L, El-Bahrawy M.

Pathol Int. 2019 Apr;69(4):193-201. doi: 10.1111/pin.12778. Epub 2019 Feb 27.

7.

Anti-tumour activity of a first-in-class agent NUC-1031 in patients with advanced cancer: results of a phase I study.

Blagden SP, Rizzuto I, Suppiah P, O'Shea D, Patel M, Spiers L, Sukumaran A, Bharwani N, Rockall A, Gabra H, El-Bahrawy M, Wasan H, Leonard R, Habib N, Ghazaly E.

Br J Cancer. 2018 Oct;119(7):815-822. doi: 10.1038/s41416-018-0244-1. Epub 2018 Sep 12.

8.

Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study.

Rambau PF, Vierkant RA, Intermaggio MP, Kelemen LE, Goodman MT, Herpel E, Pharoah PD, Kommoss S, Jimenez-Linan M, Karlan BY, Gentry-Maharaj A, Menon U, Polo SH, Candido Dos Reis FJ, Doherty JA, Gayther SA, Sharma R, Larson MC, Harnett PR, Hatfield E, de Andrade JM, Nelson GS, Steed H, Schildkraut JM, Carney ME, Høgdall E, Whittemore AS, Widschwendter M, Kennedy CJ, Wang F, Wang Q, Wang C, Armasu SM, Daley F, Coulson P, Jones ME, Anglesio MS, Chow C, de Fazio A, García-Closas M, Brucker SY, Cybulski C, Harris HR, Hartkopf AD, Huzarski T, Jensen A, Lubiński J, Oszurek O, Benitez J, Mina F, Staebler A, Taran FA, Pasternak J, Talhouk A, Rossing MA, Hendley J; AOCS Group, Edwards RP, Fereday S, Modugno F, Ness RB, Sieh W, El-Bahrawy MA, Winham SJ, Lester J, Kjaer SK, Gronwald J, Sinn P, Fasching PA, Chang-Claude J, Moysich KB, Bowtell DD, Hernandez BY, Luk H, Behrens S, Shah M, Jung A, Ghatage P, Alsop J, Alsop K, García-Donas J, Thompson PJ, Swerdlow AJ, Karpinskyj C, Cazorla-Jiménez A, García MJ, Deen S, Wilkens LR, Palacios J, Berchuck A, Koziak JM, Brenton JD, Cook LS, Goode EL, Huntsman DG, Ramus SJ, Köbel M.

J Pathol Clin Res. 2018 Oct;4(4):250-261. doi: 10.1002/cjp2.109. Epub 2018 Sep 21.

9.

Biomarker Assessment of HR Deficiency, Tumor BRCA1/2 Mutations, and CCNE1 Copy Number in Ovarian Cancer: Associations with Clinical Outcome Following Platinum Monotherapy.

Stronach EA, Paul J, Timms KM, Hughes E, Brown K, Neff C, Perry M, Gutin A, El-Bahrawy M, Steel JH, Liu X, Lewsley LA, Siddiqui N, Gabra H, Lanchbury JS, Brown R.

Mol Cancer Res. 2018 Jul;16(7):1103-1111. doi: 10.1158/1541-7786.MCR-18-0034. Epub 2018 May 3.

10.

The surgical intelligent knife distinguishes normal, borderline and malignant gynaecological tissues using rapid evaporative ionisation mass spectrometry (REIMS).

Phelps DL, Balog J, Gildea LF, Bodai Z, Savage A, El-Bahrawy MA, Speller AV, Rosini F, Kudo H, McKenzie JS, Brown R, Takáts Z, Ghaem-Maghami S.

Br J Cancer. 2018 May;118(10):1349-1358. doi: 10.1038/s41416-018-0048-3. Epub 2018 Apr 19.

11.

Ovarian leiomyoma with myxoid stroma.

Moulla A, Magdy N, El-Bahrawy M.

Pathologica. 2017 Dec;109(4):389-391.

PMID:
29449730
12.

The Tumor-Suppressor Protein OPCML Potentiates Anti-EGFR- and Anti-HER2-Targeted Therapy in HER2-Positive Ovarian and Breast Cancer.

Zanini E, Louis LS, Antony J, Karali E, Okon IS, McKie AB, Vaughan S, El-Bahrawy M, Stebbing J, Recchi C, Gabra H.

Mol Cancer Ther. 2017 Oct;16(10):2246-2256. doi: 10.1158/1535-7163.MCT-17-0081. Epub 2017 Aug 3.

13.

Ultrasound-Guided Laparoscopic Ovarian Wedge Resection in Recurrent Serous Borderline Ovarian Tumours.

Jones BP, Saso S, Farren J, El-Bahrawy M, Ghaem-Maghami S, Smith JR, Yazbek J.

Int J Gynecol Cancer. 2017 Nov;27(9):1813-1818. doi: 10.1097/IGC.0000000000001096.

PMID:
28763365
14.

Superficial Automated Keratopigmentation for Iris and Pupil Simulation Using Micronized Mineral Pigments and a New Puncturing Device: Experimental Study.

Rodriguez AE, Amesty MA, El Bahrawy M, Rey S, Alio Del Barrio J, Alio JL.

Cornea. 2017 Sep;36(9):1069-1075. doi: 10.1097/ICO.0000000000001249.

PMID:
28614152
15.

The TRAIL-Induced Cancer Secretome Promotes a Tumor-Supportive Immune Microenvironment via CCR2.

Hartwig T, Montinaro A, von Karstedt S, Sevko A, Surinova S, Chakravarthy A, Taraborrelli L, Draber P, Lafont E, Arce Vargas F, El-Bahrawy MA, Quezada SA, Walczak H.

Mol Cell. 2017 Feb 16;65(4):730-742.e5. doi: 10.1016/j.molcel.2017.01.021.

16.

Prognosis of patients with BRCA1-associated ovarian carcinomas depends on TP53 accumulation status in tumor cells.

Rzepecka IK, Szafron LM, Stys A, Felisiak-Golabek A, Podgorska A, Timorek A, Sobiczewski P, Pienkowska-Grela B, El-Bahrawy M, Kupryjanczyk J.

Gynecol Oncol. 2017 Feb;144(2):369-376. doi: 10.1016/j.ygyno.2016.11.028. Epub 2016 Dec 7.

17.

Influence of the flap on outcomes in corneal refractive surgery with femtosecond laser: SMILE vs. FLEx.

Alió JL, El Bahrawy M, Angelov A, Ortiz D, Yébana P.

Arch Soc Esp Oftalmol. 2017 May;92(5):218-224. doi: 10.1016/j.oftal.2016.10.007. Epub 2016 Dec 1. English, Spanish.

PMID:
27916313
18.

Intraoperative ultrasound-guided laparoscopic ovarian-tissue-preserving surgery for recurrent borderline ovarian tumor.

Jones BP, Saso S, Farren J, El-Bahrawy M, Smith JR, Yazbek J.

Ultrasound Obstet Gynecol. 2017 Sep;50(3):405-406. doi: 10.1002/uog.17372. Epub 2017 Jul 27. No abstract available.

19.

Biomechanical properties of an implanted engineered tubular gut-sphincter complex.

Zakhem E, El Bahrawy M, Orlando G, Bitar KN.

J Tissue Eng Regen Med. 2017 Dec;11(12):3398-3407. doi: 10.1002/term.2253. Epub 2016 Nov 23.

PMID:
27882697
20.

Positivity rate of TTF-1 on immunohistochemistry in pancreatic neuroendocrine tumors.

Wang J, Trivedi P, El-Bahrawy M.

Pathol Int. 2016 Dec;66(12):708-709. doi: 10.1111/pin.12473. Epub 2016 Nov 8. No abstract available.

21.

Primary Ovarian Malignant PEComa: A Case Report.

Westaby JD, Magdy N, Fisher C, El-Bahrawy M.

Int J Gynecol Pathol. 2017 Jul;36(4):400-404. doi: 10.1097/PGP.0000000000000331.

22.

The significance of c.690G>T polymorphism (rs34529039) and expression of the CEBPA gene in ovarian cancer outcome.

Konopka B, Szafron LM, Kwiatkowska E, Podgorska A, Zolocinska A, Pienkowska-Grela B, Dansonka-Mieszkowska A, Balcerak A, Lukasik M, Stachurska A, Timorek A, Spiewankiewicz B, El-Bahrawy M, Kupryjanczyk J.

Oncotarget. 2016 Oct 11;7(41):67412-67424. doi: 10.18632/oncotarget.11822.

23.

Synergy between histone deacetylase inhibitors and DNA-damaging agents is mediated by histone deacetylase 2 in colorectal cancer.

Alzoubi S, Brody L, Rahman S, Mahul-Mellier AL, Mercado N, Ito K, El-Bahrawy M, Silver A, Boobis A, Bell JD, Hajji N.

Oncotarget. 2016 Jul 12;7(28):44505-44521. doi: 10.18632/oncotarget.9887.

24.

Differential expression of E-cadherin and catenins in ovarian sex cord stromal tumours.

Stavrinou S, Clark A, Irving J, Lee CH, Oliva E, Young R, Sriraksa R, Magdy N, Van Noorden S, McCluggage WG, El-Bahrawy M.

Histopathology. 2016 Aug;69(2):298-306. doi: 10.1111/his.12937. Epub 2016 Mar 22.

25.

Rare Skin Adnexal and Melanocytic Tumors Arising in Ovarian Mature Cystic Teratomas: A Report of 3 Cases and Review of the Literature.

Moulla AA, Magdy N, Francis N, Taube J, Ronnett BM, El-Bahrawy M.

Int J Gynecol Pathol. 2016 Sep;35(5):448-55. doi: 10.1097/PGP.0000000000000278. Review.

26.

The status of epidermal growth factor receptor in borderline ovarian tumours.

Showeil R, Romano C, Valganon M, Lambros M, Trivedi P, Van Noorden S, Sriraksa R, El-Kaffash D, El-Etreby N, Natrajan R, Foroni L, Osborne R, El-Bahrawy M.

Oncotarget. 2016 Mar 1;7(9):10568-77. doi: 10.18632/oncotarget.7257.

27.

Keratopigmentation to Change the Apparent Color of the Human Eye: A Novel Indication for Corneal Tattooing.

Alió JL, Rodriguez AE, El Bahrawy M, Angelov A, Zein G.

Cornea. 2016 Apr;35(4):431-7. doi: 10.1097/ICO.0000000000000745.

PMID:
26845312
28.

Metabonomic analysis of ovarian tumour cyst fluid by proton nuclear magnetic resonance spectroscopy.

Kyriakides M, Rama N, Sidhu J, Gabra H, Keun HC, El-Bahrawy M.

Oncotarget. 2016 Feb 9;7(6):7216-26. doi: 10.18632/oncotarget.6891.

29.

DNA methylation profiling to assess pathogenicity of BRCA1 unclassified variants in breast cancer.

Flower KJ, Shenker NS, El-Bahrawy M, Goldgar DE, Parsons MT; KConFab Investigators; Affect Study Group, Spurdle AB, Morris JR, Brown R, Flanagan JM.

Epigenetics. 2015;10(12):1121-32. doi: 10.1080/15592294.2015.1111504.

30.

The RNA-binding protein LARP1 is a post-transcriptional regulator of survival and tumorigenesis in ovarian cancer.

Hopkins TG, Mura M, Al-Ashtal HA, Lahr RM, Abd-Latip N, Sweeney K, Lu H, Weir J, El-Bahrawy M, Steel JH, Ghaem-Maghami S, Aboagye EO, Berman AJ, Blagden SP.

Nucleic Acids Res. 2016 Feb 18;44(3):1227-46. doi: 10.1093/nar/gkv1515. Epub 2015 Dec 29.

31.

Excimer laser 6(th) generation: state of the art and refractive surgical outcomes.

El Bahrawy M, Alió JL.

Eye Vis (Lond). 2015 Mar 1;2:6. doi: 10.1186/s40662-015-0015-5. eCollection 2015. Review.

32.

Dose-Finding Quantitative 18F-FDG PET Imaging Study with the Oral Pan-AKT Inhibitor GSK2141795 in Patients with Gynecologic Malignancies.

Gungor H, Saleem A, Babar S, Dina R, El-Bahrawy MA, Curry E, Rama N, Chen M, Pickford E, Agarwal R, Blagden S, Carme S, Salinas C, Madison S, Krachey E, Santiago-Walker A, Smith DA, Morris SR, Stronach EA, Gabra H.

J Nucl Med. 2015 Dec;56(12):1828-35. doi: 10.2967/jnumed.115.156505. Epub 2015 Oct 1.

33.

The role of interleukin-8 (IL-8) and IL-8 receptors in platinum response in high grade serous ovarian carcinoma.

Stronach EA, Cunnea P, Turner C, Guney T, Aiyappa R, Jeyapalan S, de Sousa CH, Browne A, Magdy N, Studd JB, Sriraksa R, Gabra H, El-Bahrawy M.

Oncotarget. 2015 Oct 13;6(31):31593-603. doi: 10.18632/oncotarget.3415.

34.

Transcriptional implications of intragenic DNA methylation in the oestrogen receptor alpha gene in breast cancer cells and tissues.

Shenker NS, Flower KJ, Wilhelm-Benartzi CS, Dai W, Bell E, Gore E, El Bahrawy M, Weaver G, Brown R, Flanagan JM.

BMC Cancer. 2015 May 1;15:337. doi: 10.1186/s12885-015-1335-5.

35.

Cancer cell-autonomous TRAIL-R signaling promotes KRAS-driven cancer progression, invasion, and metastasis.

von Karstedt S, Conti A, Nobis M, Montinaro A, Hartwig T, Lemke J, Legler K, Annewanter F, Campbell AD, Taraborrelli L, Grosse-Wilde A, Coy JF, El-Bahrawy MA, Bergmann F, Koschny R, Werner J, Ganten TM, Schweiger T, Hoetzenecker K, Kenessey I, Hegedüs B, Bergmann M, Hauser C, Egberts JH, Becker T, Röcken C, Kalthoff H, Trauzold A, Anderson KI, Sansom OJ, Walczak H.

Cancer Cell. 2015 Apr 13;27(4):561-73. doi: 10.1016/j.ccell.2015.02.014. Epub 2015 Apr 2.

36.

Recurrent chromosomal gains and heterogeneous driver mutations characterise papillary renal cancer evolution.

Kovac M, Navas C, Horswell S, Salm M, Bardella C, Rowan A, Stares M, Castro-Giner F, Fisher R, de Bruin EC, Kovacova M, Gorman M, Makino S, Williams J, Jaeger E, Jones A, Howarth K, Larkin J, Pickering L, Gore M, Nicol DL, Hazell S, Stamp G, O'Brien T, Challacombe B, Matthews N, Phillimore B, Begum S, Rabinowitz A, Varela I, Chandra A, Horsfield C, Polson A, Tran M, Bhatt R, Terracciano L, Eppenberger-Castori S, Protheroe A, Maher E, El Bahrawy M, Fleming S, Ratcliffe P, Heinimann K, Swanton C, Tomlinson I.

Nat Commun. 2015 Mar 19;6:6336. doi: 10.1038/ncomms7336.

37.

A Unique Case of Extraovarian Sex-Cord Stromal Fibrosarcoma, With Subsequent Relapse of Differentiated Sex-Cord Tumor.

Wang J, Papanastasopoulos P, Savage P, Smith JR, Fisher C, El-Bahrawy MA.

Int J Gynecol Pathol. 2015 Jul;34(4):363-8. doi: 10.1097/PGP.0000000000000151.

38.

Expression profile of mucins (MUC1, MUC2, MUC5AC, and MUC6) in ovarian mucinous tumours: changes in expression from benign to malignant tumours.

Wang J, El-Bahrawy M.

Histopathology. 2015 Mar;66(4):529-35. doi: 10.1111/his.12578. Epub 2014 Dec 23.

PMID:
25298197
39.

Current morphologic criteria perform poorly in identifying hereditary leiomyomatosis and renal cell carcinoma syndrome-associated uterine leiomyomas.

Alsolami S, El-Bahrawy M, Kalloger SE, AlDaoud N, Pathak TB, Chung CT, Mulligan AM, Tomlinson IP, Pollard PJ, Gilks CB, McCluggage WG, Clarke BA.

Int J Gynecol Pathol. 2014 Nov;33(6):560-7. doi: 10.1097/PGP.0000000000000091. Erratum in: Int J Gynecol Pathol. 2015 Mar;34(2):213. Cheung, Catherine T [corrected to Chung, Catherine T].

PMID:
25272294
40.

The frequency and significance of WT-1 expression in serous endometrial carcinoma.

Hedley C, Sriraksa R, Showeil R, Van Noorden S, El-Bahrawy M.

Hum Pathol. 2014 Sep;45(9):1879-84. doi: 10.1016/j.humpath.2014.05.009. Epub 2014 Jun 4.

PMID:
25033726
41.

Expression profiling and significance of VEGF-A, VEGFR2, VEGFR3 and related proteins in endometrial carcinoma.

Wang J, Taylor A, Showeil R, Trivedi P, Horimoto Y, Bagwan I, Ewington L, Lam EW, El-Bahrawy MA.

Cytokine. 2014 Aug;68(2):94-100. doi: 10.1016/j.cyto.2014.04.005. Epub 2014 May 4.

PMID:
24845798
42.

Tumor suppressor role of phospholipase C epsilon in Ras-triggered cancers.

Martins M, McCarthy A, Baxendale R, Guichard S, Magno L, Kessaris N, El-Bahrawy M, Yu P, Katan M.

Proc Natl Acad Sci U S A. 2014 Mar 18;111(11):4239-44. doi: 10.1073/pnas.1311500111. Epub 2014 Mar 3.

43.

Expression profile of mucins in ovarian mucinous tumors: distinguishing primary ovarian from metastatic tumors.

Wang J, El-Bahrawy MA.

Int J Gynecol Pathol. 2014 Mar;33(2):166-75. doi: 10.1097/PGP.0b013e318288b384.

PMID:
24487472
44.

Frozen section in gynaecology: uses and limitations.

El-Bahrawy M, Ganesan R.

Arch Gynecol Obstet. 2014 Jun;289(6):1165-70. doi: 10.1007/s00404-013-3135-y. Epub 2014 Jan 11. Review.

PMID:
24414404
45.

Selective CDK9 inhibition overcomes TRAIL resistance by concomitant suppression of cFlip and Mcl-1.

Lemke J, von Karstedt S, Abd El Hay M, Conti A, Arce F, Montinaro A, Papenfuss K, El-Bahrawy MA, Walczak H.

Cell Death Differ. 2014 Mar;21(3):491-502. doi: 10.1038/cdd.2013.179. Epub 2013 Dec 20.

46.

Molecular subtypes of serous borderline ovarian tumor show distinct expression patterns of benign tumor and malignant tumor-associated signatures.

Curry EW, Stronach EA, Rama NR, Wang YY, Gabra H, El-Bahrawy MA.

Mod Pathol. 2014 Mar;27(3):433-42. doi: 10.1038/modpathol.2013.130. Epub 2013 Aug 16.

47.

Heterogeneity in lung (18)FDG uptake in pulmonary arterial hypertension: potential of dynamic (18)FDG positron emission tomography with kinetic analysis as a bridging biomarker for pulmonary vascular remodeling targeted treatments.

Zhao L, Ashek A, Wang L, Fang W, Dabral S, Dubois O, Cupitt J, Pullamsetti SS, Cotroneo E, Jones H, Tomasi G, Nguyen QD, Aboagye EO, El-Bahrawy MA, Barnes G, Howard LS, Gibbs JS, Gsell W, He JG, Wilkins MR.

Circulation. 2013 Sep 10;128(11):1214-24. doi: 10.1161/CIRCULATIONAHA.113.004136. Epub 2013 Jul 30.

PMID:
23900048
48.

Meigs syndrome presenting with axillary vein thrombosis and lymphadenopathy: a case report.

Iyer R, Chow J, El-Bahrawy M, Savage P.

J Med Case Rep. 2013 Jul 15;7:182. doi: 10.1186/1752-1947-7-182.

49.

Differential expression of IL-8 and IL-8 receptors in benign, borderline and malignant ovarian epithelial tumours.

Browne A, Sriraksa R, Guney T, Rama N, Van Noorden S, Curry E, Gabra H, Stronach E, El-Bahrawy M.

Cytokine. 2013 Oct;64(1):413-21. doi: 10.1016/j.cyto.2013.05.006. Epub 2013 May 30.

PMID:
23727325
50.

A role for cytosolic fumarate hydratase in urea cycle metabolism and renal neoplasia.

Adam J, Yang M, Bauerschmidt C, Kitagawa M, O'Flaherty L, Maheswaran P, Özkan G, Sahgal N, Baban D, Kato K, Saito K, Iino K, Igarashi K, Stratford M, Pugh C, Tennant DA, Ludwig C, Davies B, Ratcliffe PJ, El-Bahrawy M, Ashrafian H, Soga T, Pollard PJ.

Cell Rep. 2013 May 30;3(5):1440-8. doi: 10.1016/j.celrep.2013.04.006. Epub 2013 May 2.

Supplemental Content

Loading ...
Support Center